N-Methyl-2-piperidone → 1-(3-Chlorophenyl)-3-(1-methyl-2-piperidylidene)-2(1H,3H)-indolone
反応式
[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[CH2:10][C:9]2=[O:17])[CH:5]=[CH:6][CH:7]=1.[CH3:18][N:19]1[CH2:24][CH2:23][CH2:22][CH2:21][C:20]1=O>CCCCCC>[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[C:10](=[C:20]3[CH2:21][CH2:22][CH2:23][CH2:24][N:19]3[CH3:18])[C:9]2=[O:17])[CH:5]=[CH:6][CH:7]=1参加物
4
実験手順
By the procedure of Example B1, but using 1:1 hexane:ethyl acetate as chromatography eluant and pentane for crystallization, 1-(3-chlorophenyl-2-(1H,3H)-indolone (2.0 g, 8.2 mmoles) and N-methyl-2-piperidone (1.3 ml, 11.5 mmoles) were converted to title product, 180 mg (6.5%) m.p. 162°-165°.
後処理
- customethyl acetate as chromatography eluant and pentane for crystallization
出典と根拠
- ORDレコード
- ord-64224024a6b74cdc82f5ac1522e51601
- 出典データセット
- uspto-grants-1989_11
- 特許番号
- US04879391
反応ノート
読み込み中…